1-1 of 1
Michelle A. O'Brien
Close
Sort by
Journal Articles

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

Clinical Trials & Observations
John A. Liu Yin, Michelle A. O'Brien, Robert K. Hills, Sarah B. Daly, Keith Wheatley, Alan K. Burnett
Journal: Blood
Blood (2012) 120 (14): 2826–2835.
https://doi.org/10.1182/blood-2012-06-435669
Published: 2012
Includes: Supplemental data